Covagen

Contact
covagen.com
+41446356033

Covagen AG

Winterthurerstrasse 190
8057 Zürich
Switzerland
+41446356033
covagen.com
Contact
Profile Products News
Contact

About Covagen

Covagen develops next generation protein drugs for the treatment of inflammatory diseases and cancer by using its proprietary protein engineering technology, which has been developed at ETH Zurich (Switzerland). Covagen's innovative platform comprises the recently developed Covalent DNA Display technology and a novel single domain protein scaffold, which - in analogy to antibodies - can be engineered to yield high affinity binding proteins called Fynomers that can be used for therapeutic applications.

Read more about Covagen
Facts about Covagen
  • Focus : Manufacturer
  • Industry : Biotechnology

Product portfolio of Covagen

Product portfolio

Show all

News about Covagen

Covagen

27-Aug-2014 | business & finance

Janssen Affiliate Cilag GmbH International Acquires Covagen AG

Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced that it has acquired Covagen AG, a privately ...

Read news
Covagen

22-Sep-2011 | people

Sir Gregory Winter joins Covagen’s Scientific Advisory Board

Covagen announced that Sir Gregory Winter is joining its Scientific Advisory Board. Sir Gregory Winter is a member of the Medical Research Council’s ...

Read news
Covagen

18-May-2011 | people

Covagen nominates Franz Hefti as new member of the Board of Directors

Covagen announced the nomination of Dr. Franz Hefti to its Board of Directors. Franz Hefti is currently Chief Scientific Officer of Avid Radiopharmaceutical ...

Read news
Covagen

10-Mar-2011 | people

Covagen nominates Frank Walsh as Executive Chairman and appoints Mathias Locher as Chief Development Officer

Covagen announced the nomination of Prof. Frank Walsh as its new Executive Chairman of the Board and the appointment of Dr. Mathias Locher as Chief ...

Read news
Covagen

10-Nov-2010 | business & finance

Covagen and Roche extend collaboration on the use of Fynomers in drug discovery

Covagen announced that the collaboration with Roche, which began in 2009, has been extended. Under the new agreement, Covagen will use its proprietary ...

Read news
Covagen

09-Apr-2010 | people

Thierry Hercend joins Covagen’s Scientific Advisory Board

Covagen announced that it has further strengthened its Scientific Advisory Board (SAB), which will be expanded by the addition of Dr. Thierry Hercend. Dr. ...

Read news
Covagen

24-Aug-2009 | people

Franz Hefti and Ulrich Feige join Covagen’s Scientific Advisory Board

Covagen has announced the appointment of Dr. Franz Hefti and Dr. Ulrich Feige as members of its Scientific Advisory Board. Dr. Franz Hefti is currently ...

Read news
Covagen

23-Jun-2009 | business & finance

Covagen and Roche start collaboration

Covagen and Roche announced that they have entered a collaboration agreement under which Covagen will use its protein engineering technology to isolate ...

Read news
Show more news about Covagen

Here you will find Covagen AG